Phase 2 Parallel Clinical Study to Evaluate the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Gel Form Applied to Women with Sexual Arousal Disorder
Latest Information Update: 28 Oct 2024
At a glance
- Drugs BZ 371A (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- Sponsors Biozeus
- 24 Oct 2024 New trial record